Log in
Enquire now
‌

US Patent 10017520 Myc modulators and uses thereof

Patent 10017520 was granted and assigned to Massachusetts Institute of Technology on July, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Massachusetts Institute of Technology
Massachusetts Institute of Technology
0
Date Filed
December 10, 2015
0
Date of Patent
July 10, 2018
0
Patent Applicant
Massachusetts Institute of Technology
Massachusetts Institute of Technology
0
Patent Application Number
14965549
0
Patent Citations Received
‌
US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor
0
‌
US Patent 11465981 Heterocyclic compounds as immunomodulators
‌
US Patent 11414433 Heterocyclic compounds as immunomodulators
‌
US Patent 11866435 Heterocyclic compounds as immunomodulators
0
‌
US Patent 11866434 Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
0
‌
US Patent 11866451 Salts and crystalline forms of a PD-1/PD-L1 inhibitor
0
‌
US Patent 11873309 Heterocyclic compounds as immunomodulators
0
‌
US Patent 11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors
‌
US Patent 11518772 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
‌
US Patent 11535615 Heterocyclic compounds as immunomodulators
0
•••
Patent Inventor Names
Eric Stefan
0
Francisco Caballero
0
Angela N. Koehler
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10017520
0
Patent Primary Examiner
‌
Laura L. Stockton
0

Find more entities like US Patent 10017520 Myc modulators and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.